FINWIRES · TerminalLIVE
FINWIRES

Needham & Co Initiates Coverage on Lyell Immunopharma With Strong Buy Rating, $44 Price Target

By

Lyell Immunopharma (LYEL) has an average rating of Buy and mean price target of $40.50, according to analysts polled by FactSet.